Proleukin in Combination With Rituxan in Patients With Intermediate and High-Grade Non-Hodgkin's Lymphoma.

Completed · Phase 2

Conditions studied: Lymphoma, Non-Hodgkin

In brief

The purpose of this study is to determine the safety and effectiveness of combination therapy with Proleukin and Rituxan on patients with intermediate-and high- grade Non-Hodgkin's lymphoma.

Key facts

Study ID

NCT00045864

Run by

Chiron Corporation

Last updated by the study team

2006-02-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• ACRC/Arizona Clinical Research Center, Inc. — Tucson, Arizona, United States
• Hoag Cancer Center — Newport Beach, California, United States
• UC Davis Cancer Center — Sacramento, California, United States
• John Wayne Cancer Institute — Santa Monica, California, United States
• Stanford University Medical Center — Stanford, California, United States
• California Cancer Medical Center — West Covina, California, United States
• Georgetown University Medical Center, Lombardi Cancer Center — Washington D.C., District of Columbia, United States
• Washington Cancer Institute — Washington D.C., District of Columbia, United States
• Division of Hematology/Oncology, University of Miami School of Medicine — Miami, Florida, United States
• Northwestern University, Feinberg School of Medicine — Chicago, Illinois, United States
• Rush Cancer Institute — Chicago, Illinois, United States
• Oncology Specialists, S.C. — Park Ridge, Illinois, United States
• Cancer Care Center — Bloomington, Indiana, United States
• Consultants in Blood Disorders and Cancer — Louisville, Kentucky, United States
• Louisiana Health Sciences Center, Department of Medicine, Hematology/Oncology — Shreveport, Louisiana, United States
• Kansas City Oncology and Hematology Group — Kansas City, Missouri, United States
• Arch Medical Group, LLC — St Louis, Missouri, United States
• Dartmouth-Hitchcock-Medical Center — Lebanon, New Hampshire, United States
• Memorial Sloan Kettering Cancer Center — New York, New York, United States
• Our Lady of Mercy Medical Center, Comprehensive Cancer Center — The Bronx, New York, United States
• East Carolina University School of Medicine/ Division of Hematology/Oncology — Greenville, North Carolina, United States
• Roger Maris Health System — Fargo, North Dakota, United States
• Gabrail Cancer Center — Canton, Ohio, United States
• Oncology Hematology Care Inc. — Cincinnati, Ohio, United States
• The Cleveland Clinic Foundation — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.